mCDS71
Alternative Names: Modified cyclodextrin sulfate - Tanabe SeiyakuLatest Information Update: 14 Jul 1998
At a glance
- Originator Tanabe Seiyaku
- Developer Nonindustrial source; Tanabe Seiyaku
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 14 Jul 1998 No-Development-Reported for HIV-1 infections in Japan (PO)
- 23 Nov 1995 Preclinical development for HIV-1 infections in Japan (Unknown route)